| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.18B | 133.59B | 128.07B | 134.30B | 114.50B | 114.79B |
| Gross Profit | 27.29B | 28.03B | 27.39B | 27.59B | 25.04B | 24.44B |
| EBITDA | 5.48B | 5.54B | 4.92B | 4.57B | 4.34B | 5.22B |
| Net Income | 2.11B | 2.08B | 1.85B | 1.65B | 2.20B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 78.26B | 79.43B | 79.27B | 84.20B | 69.55B | 58.91B |
| Cash, Cash Equivalents and Short-Term Investments | 4.88B | 3.96B | 3.83B | 3.09B | 4.54B | 5.19B |
| Total Debt | 26.79B | 26.68B | 20.04B | 29.86B | 22.40B | 15.28B |
| Total Liabilities | 54.89B | 56.19B | 56.48B | 62.95B | 50.21B | 41.37B |
| Stockholders Equity | 23.37B | 23.24B | 22.79B | 21.25B | 19.35B | 17.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.74B | 10.85B | -7.25B | -4.76B | 5.85B |
| Operating Cash Flow | 0.00 | -2.88B | 12.47B | -3.65B | -1.63B | 6.97B |
| Investing Cash Flow | 0.00 | -1.83B | -2.17B | -3.96B | -4.01B | -1.66B |
| Financing Cash Flow | 0.00 | 4.86B | -9.48B | 6.16B | 4.79B | -2.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥226.67B | 16.88 | ― | 2.83% | 1.49% | -21.76% | |
67 Neutral | ¥178.62B | 11.31 | ― | 1.58% | 1.69% | 3.90% | |
67 Neutral | ¥138.10B | 12.62 | ― | 2.85% | 3.83% | 7.24% | |
66 Neutral | ¥130.16B | 8.26 | ― | 3.43% | 0.73% | -9.78% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥63.09B | 19.77 | 0.36% | 2.78% | -6.21% | -29.75% | |
54 Neutral | ¥29.48B | 7.77 | ― | 1.66% | 1.84% | -14.00% |